Condensed financial statements

Consolidated income statement

EUR million	Q3 2026	Q3 2025¹	9M 2026	9M 2025¹	LTM	FY 2025¹
Continuing operations
Revenue	570.8	538.7	1,721.6	1,618.0	2,281.0	2,177.4
Operating expenses
Medical provision costs	-429.6	-408.5	-1,296.8	-1,225.4	-1,726.2	-1,654.8
Gross profit	141.2	130.2	424.8	392.6	554.8	522.6
Distribution, selling and marketing costs	-24.4	-23.9	-77.8	-74.4	-102.0	-98.6
Administrative costs	-67.5	-65.9	-202.0	-200.2	-273.3	-271.5
Operating profit (EBIT)	49.3	40.4	145.0	118.0	179.5	152.5
Other income/(costs)	-0.2	-0.7	-0.2	1.1	0.3	1.6
Interest income	1.1	1.1	3.0	2.9	3.9	3.8
Interest expense	-13.5	-12.9	-38.8	-37.7	-51.1	-50.0
Other financial income/(expense)	-4.0	-1.2	-9.2	0.0	-8.5	0.7
Total financial result	-16.4	-13.0	-45.0	-34.8	-55.7	-45.5
Share of profit/(loss) of associates	0.0	0.0	0.0	0.2	-0.1	0.1
Profit before income tax	32.7	26.7	99.8	84.5	124.0	108.7
Income tax	-7.9	-7.5	-28.0	-25.4	-33.1	-30.5
Profit from continuing operations	24.8	19.2	71.8	59.1	90.9	78.2

Discontinued operations
Profit/(loss) from discontinued operations	0.4	-0.6	-2.2	-3.7	-4.0	-5.5
Profit for the period, Group total	25.2	18.6	69.6	55.4	86.9	72.7
Profit attributable to:
Owners of the parent	25.7	19.5	72.2	58.7	91.0	77.5
Non-controlling interests	-0.5	-0.9	-2.6	-3.3	-4.1	-4.8
Profit for the period	25.2	18.6	69.6	55.4	86.9	72.7

Earnings per share, continuing operations:
Basic, €	0.162	0.127	0.471	0.391	0.600	0.519
Diluted, €	0.162	0.127	0.470	0.390	0.598	0.518
Earnings per share, Group total:
Basic, €	0.169	0.129	0.476	0.390	0.601	0.514
Diluted, €	0.169	0.129	0.475	0.389	0.599	0.513

¹Comparative figures have been restated to reflect the classification of Medicover Hospitals India as a discontinued operation.